Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors

Sabrina Rossi, Luca Toschi, Giovanna Finocchiaro, Vincenzo Di Noia, Maria Bonomi, Eleonora Cerchiaro, Giovanni Luca Ceresoli, Giordano Domenico Beretta, Ettore D'Argento, Armando Santoro

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences